| Literature DB >> 19003294 |
Abstract
Hundreds of misleading reports are published every year containing data on human cancer cell lines that are derived from some other species, tissue or individual to that claimed. In consequence, millions of dollars provided for cancer research are being spent on the production of misleading data. This review describes how cross-contamination occurs, catalogues the use of false cell lines in leading biomedical journals, and suggests ways to resolve the problem.Entities:
Year: 2002 PMID: 19003294 PMCID: PMC3463980 DOI: 10.1023/A:1022908930937
Source DB: PubMed Journal: Cytotechnology ISSN: 0920-9069 Impact factor: 2.058